Stock Movers Bayer Rises, Persimmon Gains, Santander Polska Down
Dec 2, 2025
Chloe Millay, a Bloomberg reporter known for her insights into European stocks, dives into some hot topics. She discusses Bayer's appeal to the Supreme Court, which has boosted its stock amid ongoing litigation about Roundup's cancer claims. The rising UK house prices are lifting shares for Persimmon, showing market resilience despite potential tax hikes. Additionally, she covers Santander's gradual disposal of its Polish subsidiary and plans to reinvest proceeds for growth in the Americas.
AI Snips
Chapters
Transcript
Episode notes
Legal Win Could Reset Bayer's Liability
- Bayer's stock jumped after the Trump administration asked the US Supreme Court to hear its appeal over Roundup litigation.
- The move could invalidate thousands of cases and lessen Bayer's massive litigation costs tied to Monsanto's product.
Roundup Litigation Has Deeply Hurt Bayer
- Litigation has crushed Bayer's value, with the stock down about 70% since the Monsanto deal in 2018.
- A successful appeal could substantially reduce future settlements and restore investor confidence.
UK Housing Market Shows Resilience
- UK house prices rose for a third consecutive month, pushing Persimmon and other builders higher.
- The data suggests housing demand stayed resilient despite pre-budget tax-hike fears and the mansion tax reports.